PATENT CLAIM ANALYSIS

Application Number: 16028790
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["514", "182000"]

Abstract:
Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X, Y, R 1 , R 2a , R 2b , R 4a , R 4b , R 5a , R 5b , R 6a , R 6b , R 7 , and R 8  are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claim (Index 46):
A method for treating a disorder selected from the group consisting of a gastrointestinal (GI) disorder, inflammatory bowel disease (IBD), structural disorders affecting the GI, anal disorders, colon polyps, cancer, diabetes, and colitis, the method comprising administering to a subject in need thereof an effective amount of a compound having the following structure: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 95.0
- Lexical Diversity: 1.66
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15319504', '15319503', '15917263', '16020641', '15297845']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7465254603576306
- 35 USC 102 Novelty (BERT): 0.5285366343718837
- Combined Prediction Score: 0.7247265777590559
- Mean Citation Score: 307.591422
- Max Citation Score: 335.86813
- Similarity Product: 211.4887560174221

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test